Quince Therapeutics, Inc. (QNCX)
NASDAQ: QNCX · Real-Time Price · USD
1.530
-0.010 (-0.65%)
At close: Nov 4, 2024, 4:00 PM
1.520
-0.010 (-0.68%)
After-hours: Nov 4, 2024, 6:22 PM EST

Quince Therapeutics Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2019 2018 - 2017
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19 2018 - 2017
Market Capitalization
6645233778191,507
Upgrade
Market Cap Growth
-40.62%95.46%-93.89%-53.99%-45.64%-
Upgrade
Enterprise Value
21-38-712646821,387
Upgrade
Last Close Price
1.531.050.6412.6227.7856.14
Upgrade
PE Ratio
--1.25-0.41-4.17-10.55-28.89
Upgrade
PB Ratio
1.410.530.233.184.7613.05
Upgrade
P/FCF Ratio
-1.15-2.44-0.52-5.97-16.11-45.23
Upgrade
P/OCF Ratio
-1.16-2.46-0.52-5.99-16.13-45.30
Upgrade
EV/EBITDA Ratio
0.731.571.42-2.93-8.68-35.58
Upgrade
EV/EBIT Ratio
0.721.551.42-2.92-8.65-35.41
Upgrade
EV/FCF Ratio
0.762.071.60-4.18-13.41-41.61
Upgrade
Debt / Equity Ratio
0.310.160.000.010.00-
Upgrade
Debt / FCF Ratio
-0.51-0.75-0.01-0.02-0.01-
Upgrade
Quick Ratio
5.857.9529.717.597.8711.23
Upgrade
Current Ratio
6.158.0930.557.858.1111.93
Upgrade
Return on Equity (ROE)
-79.38%-33.81%-47.14%-61.85%-53.42%-39.57%
Upgrade
Return on Assets (ROA)
-16.50%-11.33%-26.40%-34.99%-31.42%-24.82%
Upgrade
Return on Capital (ROIC)
-24.87%-15.41%-28.36%-38.60%-34.22%-26.20%
Upgrade
Earnings Yield
-80.23%-69.73%-224.32%-23.85%-9.38%-2.45%
Upgrade
FCF Yield
-42.42%-40.99%-191.80%-16.74%-6.21%-2.21%
Upgrade
Buyback Yield / Dilution
-14.07%-11.17%-12.71%-1.86%-53.30%-466.06%
Upgrade
Total Shareholder Return
-14.07%-11.17%-12.71%-1.86%-53.30%-466.06%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.